Portfolio company
Videm
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Videm develops a handheld diagnostic device for rapid molecular and protein detection of infectious diseases in care settings and at home.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Rapidemic
Rapidemic develops molecular point-of-care diagnostic tests for sexually transmitted infections, providing results for patients and clinicians without requiring laboratory infrastructure or external power.
AltraTech
AltraTech develops portable molecular diagnostic platforms for point-of-care testing of DNA, RNA, and antibodies for healthcare providers and the agrifood sector.
Visby Medical
This company develops portable, single-use molecular diagnostic devices for clinicians and consumers to detect infectious diseases, including respiratory and sexual health conditions.
Enzyre
This company develops a portable diagnostic device for haemophilia patients to monitor blood coagulation status and manage treatment from home.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
LEUKO
This company develops a non-invasive device for monitoring white blood cell levels at home for cancer patients undergoing chemotherapy.
Slive
This company develops point-of-care diagnostic tests for clinicians to improve the speed and accuracy of medical screenings.
Deepull
Deepull develops automated diagnostic systems that identify pathogens and antibiotic resistance directly from blood samples for healthcare providers treating sepsis and acute infections.